The Oral GLP-1 Pill Tracker App, Built for a Daily Tablet

Almost everything written about GLP-1 tracking was written for an injection, and an injection is a memorable event. You get the pen out, you choose a site, you feel it happen. A week later you can usually say with some confidence whether you did it.

A tablet does not work like that. It happens standing at the kitchen counter, before coffee, inside the same thirty seconds as the rest of your morning. By Thursday, the memory of Tuesday's tablet is indistinguishable from the memory of Monday's and Wednesday's, because all three were the same thirty seconds. The failure mode inverts: with a shot, the risk is forgetting; with a pill, the risk is not knowing whether you already took it.

That inversion changes what a tracker is actually for. On a weekly medication, the reminder is the valuable half, because it is the thing that stops a dose from slipping past a busy week. On a daily one, the reminder is the smaller half. The log earns its keep instead, because a log is the only thing that can answer a question about the past. A notification you swiped away leaves nothing behind. A logged entry does.

There is a quieter advantage to a daily medication that people rarely expect: the record is far richer. A weekly medication produces roughly fifty-two entries in a year. One missed dose is a single gap in a short list, and a single gap in a short list is just a gap. There is not much shape to read in it.

A daily tablet produces three hundred and sixty-five. At that density, patterns become visible. You can see that the misses cluster at weekends, or on travel days, or in the fortnight after your schedule changed. You can see a streak, and you can see how it ended. You can see whether the days you took it later than usual line up with anything else you happened to be logging. None of that resolves on a weekly cadence, because there simply are not enough points to make a pattern out of.

GLP-1 Tracker keeps that history as a scrollable timeline with a streak running alongside it. It does not interpret the pattern for you. It is not a diagnostic tool, it draws no conclusions about your treatment, and it has no opinion about a gap. It makes the shape visible, which is usually all you need in order to raise it with the person who can interpret it.

This is the part that surprises people, and it is worth understanding before you read any general advice about oral GLP-1s. Two of them can behave so differently inside the body that a rule you picked up about one may be flatly wrong about the other.

Oral semaglutide, the tablet sold as Rybelsus, is a peptide. Peptides are precisely what stomach acid and digestive enzymes evolved to take apart, so most of a swallowed dose never survives the journey. The published pharmacokinetic data in the FDA prescribing information puts its absolute bioavailability at roughly one percent. That single number explains a great deal: it is why the tablet strengths are numbered so differently from the injection's, and it is why the label carries strict conditions about an empty stomach, a small sip of plain water, and a wait before anything else. Absorption also varies considerably between people and from one day to the next, which is exactly why those conditions sit on the label rather than being offered as suggestions.

Orforglipron, approved in 2026 and sold as Foundayo, is not a peptide at all. It is a small molecule, and small molecules generally survive the gut intact. Its absolute bioavailability is published at roughly seventy-seven percent, on the order of seventy-five times higher than oral semaglutide's. That is why it carries no food or water restriction.

So saying you are on an oral GLP-1 describes a route of administration and not much else. Whatever your own label says is what applies to you, and your pharmacist is the right person to walk you through it.

On a medication with timing conditions attached to it, a log that records only the date is throwing away half of what happened. Whether Tuesday's tablet happened is one question. Whether it happened at the usual time, or forty minutes later because the morning went sideways, is a different question, and on a drug whose absorption depends on the conditions around it, that is a question worth being able to answer.

None of that is an invitation to draw your own conclusions. Absorption varies for reasons no app can see, and one late morning means whatever your prescriber says it means, which may well be nothing at all. The value of a timestamp is simply that it exists. Six weeks later, when you are trying to describe your actual routine to someone who is asking, usually around seven and sometimes later at weekends is a far more useful answer than every day, I think.

GLP-1 Tracker records the time alongside the date on every logged dose. If your medication carries no timing conditions, that detail costs you nothing and you can ignore it entirely. If it does carry them, you have it without having tried to remember it.

Appointments compress. You get a short window, and a good deal of what you meant to say lives in the part of your memory that refuses to cooperate under time pressure. A log fixes that, but only if it holds the right things.

For a daily oral, the material that tends to earn its place is: the dose history itself, including any gaps and roughly when they fell; the times of day, if your medication has conditions attached to them; side effects with the dates they landed on, since when something started is often more informative than the fact that it happened; your weight or BMI trend rather than one reading taken on one morning; and any note you wrote at the time about how a stretch of days actually felt, because that is the detail that evaporates fastest.

GLP-1 Tracker keeps all of that together, and you can scroll it in front of you rather than reconstruct it on the spot. What it cannot do is interpret any of it. The app organizes what you enter; it does not diagnose, advise, or draw conclusions, and anything that worries you belongs in a conversation with your provider rather than in a tracking app.

GLP-1 Tracker is a free iPhone app made by an independent developer with no connection to any drug manufacturer. It handles daily and weekly cadences equally well, tracks Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus and Saxenda among others — both oral options included, semaglutide tablets and orforglipron — and works in 11 languages. Otis, an otter, lives on the home screen and is unreasonably pleased with you every time you log something.

Everything you enter is stored on your device and, with iCloud sync on (the default), in your own private iCloud, so it comes back on a new iPhone. We never upload your health data to our servers and we never sell it, there is no web version, and there is no account to create. It is worth saying plainly what that means: your history is yours, and nobody at this end can read it.

One thing this page will deliberately not do is tell you whether an oral or an injectable is the better option, or weigh in on moving between them. That is a prescribing decision that turns on your medical history, how you tolerate things, what your coverage allows and what your provider judges, and none of it is visible from a web page. What a tracker can do is carry on without you starting over if the form of your medication ever changes.